UCLA Health: Combination of Immunotherapy and Targeted Therapy Improves Survival for Patients With Advanced Colorectal Cancer
October 21, 2025
October 21, 2025
LOS ANGELES, California, Oct. 21 (TNSjou) -- The UCLA Health issued the following news release:
* * *
Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer
First trial to show improved survival with immunotherapy in the 95% of patients with metastatic disease who are microsatellite stable
*
A new study led by UCLA investigators found that combining zanzalintinib, a targeted . . .
* * *
Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer
First trial to show improved survival with immunotherapy in the 95% of patients with metastatic disease who are microsatellite stable
*
A new study led by UCLA investigators found that combining zanzalintinib, a targeted . . .